4-2 Final Project Milestone Three Draft Proposal Capital Budget Item Selection and Opportunities Ava

This preview shows page 1 - 3 out of 4 pages.

4-2 Final Project Milestone Three: Draft Proposal: Capital Budge Item Selection and Opportunities Available for Proposal Ian Longstreet HCM-400-T4764 Healthcare Finance 21EW4 Southern New Hampshire University – Online March 28, 2021 Prof. Jay Christensen
As the first cord bank in the US, Cryo-Cell has a unique opportunity, with their rich reputation already established in the medical industry. “ Cord Blood is the blood that remains in the vein of the umbilical cord and placenta at the time of birth. Cord blood is rich in hematopoietic stem cells, which give rise to all the other blood cells and is the foundation of our bodies’ immune system. Cord blood stem cells are already being used to treat nearly 80 diseases, including: leukemia, lymphoma, anemia, and inherited metabolic disorders” (Cryo-Cell, n.d.). Reading that statement from Cryo-Cell how could you not have hope for the future in medicine, science, and technology? Cryo-Cell International INC has a major opportunity both medically and financially.

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture